Table 7.1.
Summary of in vitro studies on the effects of GC on adiponectin expression
References | Type of GC | Concentration and duration of exposure | Culture system | Effects on adiponectin mRNA/protein expression |
---|---|---|---|---|
Downregulation | ||||
Fasshauer et al. (2003) | Dexamethasone | 100 nM for 16 h | 3T3-L1 preadipocytes | Decrease in protein expression/secretion |
Fasshauer et al. (2002) | Dexamethasone | 100 nM for 16 h | 3T3-L1 preadipocytes | Decrease in mRNA expression |
Halleux et al. (2001) | Dexamethasone | 50 nM for 20 h | Isolated adipocytes from human visceral adipose tissue | Decrease in mRNA expression |
Degawa-Yamauchi et al. (2005) | Dexamethasone | 100 nM for 48 h | Human subcutaneous adipocytes | Decrease in protein secretion |
No regulation | ||||
Hozumi et al. (2010) | Dexamethasone | 1 μM for 24 h | Human bone marrow adipocytes | No change in protein secretion |
Sakamoto et al. (2011) | Dexamethasone | 1 μM for 24 h | Human bone marrow adipocytes | No change in mRNA expression |
Ryan et al. (2010) | Dexamethasone | 2 and 20 nM for 2 and 24 h | Differentiated canine adipocytes | No change in mRNA expression |
de Oliveira, Iwanaga-Carvalho, et al. (2011b) | Dexamethasone | 1 μM for 24 h | 3T3-L1 adipocytes | No change in mRNA expression |